Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.596
-0.014 (-2.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed
MTNB Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 4 | 4 | 3 | 47 | 108 | 218 | |
| Market Cap Growth | 46.82% | 44.70% | -94.48% | -56.68% | -50.35% | -19.56% | |
| Enterprise Value | 1 | 1 | -5 | 32 | 80 | 169 | |
| Last Close Price | 0.60 | 0.59 | 0.51 | 10.81 | 25.00 | 50.50 | |
| PS Ratio | - | - | - | 42.86 | 34.01 | 6618.48 | |
| PB Ratio | 0.79 | 0.78 | 0.34 | 2.44 | 2.96 | 4.16 | |
| P/TBV Ratio | 0.79 | 0.78 | 0.34 | 2.62 | 3.07 | 4.27 | |
| EV/Sales Ratio | - | - | - | 29.62 | 24.97 | 5133.74 | |
| Debt / Equity Ratio | 0.28 | 0.28 | 0.38 | 0.19 | 0.11 | 0.09 | |
| Net Debt / Equity Ratio | -0.55 | -0.55 | -0.58 | -0.53 | -0.67 | -0.86 | |
| Net Debt / EBITDA Ratio | 0.38 | 0.38 | 0.22 | 0.44 | 1.02 | 1.84 | |
| Net Debt / FCF Ratio | 0.38 | 0.38 | 0.28 | 0.66 | 1.23 | 2.90 | |
| Asset Turnover | - | - | - | 0.03 | 0.06 | 0 | |
| Quick Ratio | 2.73 | 2.73 | 2.73 | 5.25 | 6.71 | 11.41 | |
| Current Ratio | 2.79 | 2.79 | 3.01 | 5.93 | 8.06 | 11.73 | |
| Return on Equity (ROE) | -166.59% | -166.59% | -180.74% | -82.11% | -47.12% | -40.06% | |
| Return on Assets (ROA) | -43.83% | -43.83% | -66.77% | -42.49% | -28.96% | -23.37% | |
| Return on Capital Employed (ROCE) | -121.10% | -121.10% | -202.10% | -105.70% | -60.70% | -43.40% | |
| Earnings Yield | -287.18% | -275.57% | -934.76% | -48.84% | -19.36% | -10.66% | |
| FCF Yield | -183.66% | -186.76% | -612.29% | -32.99% | -18.49% | -7.09% | |
| Buyback Yield / Dilution | -12.50% | -12.50% | -11.98% | -0.21% | -3.16% | -6.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.